334 related articles for article (PubMed ID: 28095869)
21. Macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Shimizu M
Immunol Med; 2021 Dec; 44(4):237-245. PubMed ID: 33982649
[TBL] [Abstract][Full Text] [Related]
22. Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis.
Karakike E; Giamarellos-Bourboulis EJ
Front Immunol; 2019; 10():55. PubMed ID: 30766533
[TBL] [Abstract][Full Text] [Related]
23. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.
Krei JM; Møller HJ; Larsen JB
Clin Exp Immunol; 2021 Feb; 203(2):174-182. PubMed ID: 33128796
[TBL] [Abstract][Full Text] [Related]
24. Mouse models of systemic juvenile idiopathic arthritis and macrophage activation syndrome.
Inoue N; Schulert GS
Arthritis Res Ther; 2023 Mar; 25(1):48. PubMed ID: 36964620
[TBL] [Abstract][Full Text] [Related]
25. Systemic juvenile idiopathic arthritis and macrophage activation syndrome: update on pathogenesis and treatment.
Yasin S; Schulert GS
Curr Opin Rheumatol; 2018 Sep; 30(5):514-520. PubMed ID: 29870499
[TBL] [Abstract][Full Text] [Related]
26. The genetics of macrophage activation syndrome.
Schulert GS; Cron RQ
Genes Immun; 2020 May; 21(3):169-181. PubMed ID: 32291394
[TBL] [Abstract][Full Text] [Related]
27. Haemophagocytic lymphocytic histiocytosis/macrophage activation syndrome with acute inflammatory gastroenteritis.
Kolachana S; Malik A; Nanjudappa A; Iding J; Bhansali D; Haas CJ
BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 36002177
[TBL] [Abstract][Full Text] [Related]
28. Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review.
Çakan M; Aktay-Ayaz N; Gemici H; Annayev A; Çıtak A; Akçay A; Öztürk G
Turk J Pediatr; 2018; 60(5):598-603. PubMed ID: 30968645
[TBL] [Abstract][Full Text] [Related]
29. Sudden Hypotension and Increased Serum Interferon-γ and Interleukin-10 Predict Early Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis.
Guo L; Xu Y; Qian X; Zou L; Zheng R; Teng L; Zheng Q; Leung Jung LK; Lu M
J Pediatr; 2021 Aug; 235():203-211.e3. PubMed ID: 33581106
[TBL] [Abstract][Full Text] [Related]
30. IFN-γ is essential for alveolar macrophage-driven pulmonary inflammation in macrophage activation syndrome.
Gao DK; Salomonis N; Henderlight M; Woods C; Thakkar K; Grom AA; Thornton S; Jordan MB; Wikenheiser-Brokamp KA; Schulert GS
JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34314387
[TBL] [Abstract][Full Text] [Related]
31. Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels.
Wakiguchi H; Hasegawa S; Hirano R; Kaneyasu H; Wakabayashi-Takahara M; Ohga S
Pediatr Rheumatol Online J; 2015 Nov; 13():49. PubMed ID: 26581448
[TBL] [Abstract][Full Text] [Related]
32. Macrophage activation syndrome associated with griscelli syndrome type 2: case report and review of literature.
Sefsafi Z; Hasbaoui BE; Kili A; Agadr A; Khattab M
Pan Afr Med J; 2018; 29():75. PubMed ID: 29875956
[TBL] [Abstract][Full Text] [Related]
33. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
[TBL] [Abstract][Full Text] [Related]
34. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.
Zou LX; Zhu Y; Sun L; Ma HH; Yang SR; Zeng HS; Xiao JH; Yu HG; Guo L; Xu YP; Lu MP
World J Pediatr; 2020 Feb; 16(1):89-98. PubMed ID: 31612427
[TBL] [Abstract][Full Text] [Related]
35. Interferon-γ mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice.
Canna SW; Wrobel J; Chu N; Kreiger PA; Paessler M; Behrens EM
Arthritis Rheum; 2013 Jul; 65(7):1764-75. PubMed ID: 23553372
[TBL] [Abstract][Full Text] [Related]
36. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
37. Thrombotic Microangiopathy Associated with Macrophage Activation Syndrome: A Multinational Study of 23 Patients.
Minoia F; Tibaldi J; Muratore V; Gallizzi R; Bracaglia C; Arduini A; Comak E; Vougiouka O; Trauzeddel R; Filocamo G; Mastrangelo A; Micalizzi C; Kasapcopur O; Unsal E; Kitoh T; Tsitsami E; Kostik M; Schmid JP; Prader S; Laube G; Maritsi D; Jelusic M; Shenoi S; Vastert S; Ardissino G; Cron RQ; Ravelli A;
J Pediatr; 2021 Aug; 235():196-202. PubMed ID: 33836183
[TBL] [Abstract][Full Text] [Related]
38. Implications of SARS-CoV-2 Infection in Systemic Juvenile Idiopathic Arthritis.
Ailioaie LM; Ailioaie C; Litscher G
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457086
[TBL] [Abstract][Full Text] [Related]
39. Systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome due to a CASP1 variant causing inflammasome hyperactivation.
Jørgensen SE; Christiansen M; Høst C; Glerup M; Mahler B; Lausten MM; Gad HH; Hartmann R; Herlin T; Mogensen TH
Rheumatology (Oxford); 2020 Oct; 59(10):3099-3105. PubMed ID: 32556329
[TBL] [Abstract][Full Text] [Related]
40. Macrophage activation syndrome in rheumatic disease: what is the role of the antigen presenting cell?
Behrens EM
Autoimmun Rev; 2008 Feb; 7(4):305-8. PubMed ID: 18295734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
